These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function. Gao WD; Murray CI; Tian Y; Zhong X; DuMond JF; Shen X; Stanley BA; Foster DB; Wink DA; King SB; Van Eyk JE; Paolocci N Circ Res; 2012 Sep; 111(8):1002-11. PubMed ID: 22851540 [TBL] [Abstract][Full Text] [Related]
15. Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm. Wink DA; Miranda KM; Katori T; Mancardi D; Thomas DD; Ridnour L; Espey MG; Feelisch M; Colton CA; Fukuto JM; Pagliaro P; Kass DA; Paolocci N Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2264-76. PubMed ID: 12855429 [TBL] [Abstract][Full Text] [Related]
16. Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties. Shoman ME; Aly OM Oxid Med Cell Longev; 2016; 2016():4867124. PubMed ID: 26770654 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins. A chemical discussion of the differential biological effects of these redox related products of NOS. Miranda KM; Nims RW; Thomas DD; Espey MG; Citrin D; Bartberger MD; Paolocci N; Fukuto JM; Feelisch M; Wink DA J Inorg Biochem; 2003 Jan; 93(1-2):52-60. PubMed ID: 12538052 [TBL] [Abstract][Full Text] [Related]
18. Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling. Paolocci N; Katori T; Champion HC; St John ME; Miranda KM; Fukuto JM; Wink DA; Kass DA Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5537-42. PubMed ID: 12704230 [TBL] [Abstract][Full Text] [Related]
19. Advances in research on treatment of heart failure with nitrosyl hydrogen. Guo Y; Xu J; Wu L; Deng Y; Wang J; An J Heart Fail Rev; 2019 Nov; 24(6):941-948. PubMed ID: 31069588 [TBL] [Abstract][Full Text] [Related]
20. The HNO donor Angeli's salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia-reperfusion injury in the rat heart ex vivo. Chin KY; Michel L; Qin CX; Cao N; Woodman OL; Ritchie RH Pharmacol Res; 2016 Feb; 104():165-75. PubMed ID: 26747404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]